Long-Running South African Study Reveals Persistent HIV Immune Activity in the Brain Despite Blood Viral Suppression
Researchers tracking a cohort of South African adolescents over sixteen years have reported finding persistent HIV-specific immune activity in the central nervous system, even in participants whose viral loads are fully suppressed in the bloodstream. The finding, discussed at a scientific meeting in Rio de Janeiro, Brazil, challenges the long-held assumption that suppressing HIV in the blood necessarily means the virus has become biologically quiet throughout the body.
A rare longitudinal perspective
The study is among the longest continuous HIV investigations involving a single community anywhere in the world. Beginning when its participants were children, the research has followed them through adolescence, providing an unusually detailed picture of how the virus interacts with a developing immune system over time. Such long-term observation is rare in HIV science, where most studies span only a few years and tend to focus on adult populations in high-income settings.
What the researchers observed
Despite achieving and maintaining viral suppression in the blood — the standard benchmark for successful antiretroviral therapy — some participants showed ongoing immune responses linked to HIV within the central nervous system. Scientists interpret this as evidence that the brain and spinal cord can host low-level viral activity independently of what is happening in the bloodstream. The phenomenon is consistent with broader research suggesting that HIV can establish so-called viral reservoirs in tissues that are shielded from full immune surveillance and from many antiretroviral drugs.
Why the central nervous system matters
The central nervous system is considered one of the most challenging compartments for HIV treatment. The blood-brain barrier, which normally protects the brain from pathogens and toxins, also limits the penetration of many medications. Persistent immune activation in this region has been associated in other studies with cognitive difficulties, neuroinflammation, and long-term neurological complications in people living with HIV. Understanding whether ongoing immune activity in the CNS is driven by active viral replication or by residual viral proteins is a central question for the field.
Implications for treatment and future research
The findings add to a growing body of evidence that viral suppression in the blood, while essential, may not tell the complete story of an individual’s HIV status. Researchers say the work underscores the need for therapies capable of reaching the central nervous system more effectively, as well as monitoring tools that can detect low-level activity beyond standard blood tests. For South Africa, which continues to host the largest population of people living with HIV in the world, such insights are particularly relevant to long-term care strategies for both adolescents and adults on lifelong treatment.
The study’s longevity, scientists note, also highlights the value of sustained investment in community-based research partnerships. Sixteen years of data offer a depth of insight that shorter studies cannot match, particularly for a virus whose interactions with the human body remain only partially understood more than four decades into the epidemic.
Source: AllAfrica — read the original report.
